Reza Dana

And Team of Researchers Develop a Biomaterial for Corneal Repair and Regeneration · Beth Israel Deaconess Medical Center

Credentials: · · · · ·

History

Mass Eye and Ear-Vision Clinical Scientist Development Program
National Eye Institute · K12
Contact PI · $12.3M · Massachusetts Eye and Ear Infirmary
2004–2031
Engineering Tunable Biomimetic Adhesive Hydrogel to Deliver and Enhance MSC Function for Corneal Regeneration
National Eye Institute · R01
PI · $528K · University of California Los Angeles
2026–2030
Immunopathogenic Mechanisms of Dry Eye Disease
National Eye Institute · R01
Contact PI · $7.9M · Schepens Eye Research Institute
2010–2029
The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival
National Eye Institute · R01
Contact PI · $2.4M · Schepens Eye Research Institute
2022–2027

Mucinex® for Treatment of Filamentary Keratitis
Principal investigator · Completed
Massachusetts Eye and Ear Infirmary
2016–2018
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Principal investigator · Completed · Phase 1, Phase 2
Reza Dana, MD
2014–2019
Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease
Principal investigator · Completed · Phase 1
Massachusetts Eye and Ear Infirmary
2013–2014
Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
Principal investigator · Completed · Phase 4
Massachusetts Eye and Ear Infirmary
2011–2017